Stockreport

New Data Highlight the Positive Impact of Exact Sciences' Oncotype DX® Test on Patient Care and Healthcare Efficiency [Yahoo! Finance]

Exact Sciences Corporation  (EXAS) 
Last exact sciences corporation earnings: 2/11 04:05 pm Check Earnings Report
PDF presentation of new data further reinforcing the utility of its Oncotype DX Breast Recurrence Score ® test at the th St. Gallen International Breast Cancer Conference in [Read more]